Peiyan Zhao
Overview
Explore the profile of Peiyan Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao P, Zhou H, Liao X, Zhao L, Zheng Y, Xiong T, et al.
Front Plant Sci
. 2025 Feb;
16:1530324.
PMID: 39990714
Introduction: Specific microorganisms and metabolites in soil play key roles in regulating organismal behavior. Currently, the effects of different preceding crops on the rhizosphere soil quality of flue-cured tobacco remain...
2.
Li H, Tang C, Zhao P, Zhong R, Lu Y, Liu Y, et al.
Cancer Sci
. 2025 Jan;
PMID: 39817471
There is an urgent need to develop new targeted treatment agents for small cell lung cancer (SCLC). Tinengotinib (TT-00420) is a novel, multi-targeted, and spectrally selective small-molecule kinase inhibitor that...
3.
Li H, Meng L, Wang H, Cui L, Sheng H, Zhao P, et al.
Brief Bioinform
. 2024 Dec;
26(1).
PMID: 39737564
Somatic variants play a crucial role in the occurrence and progression of cancer. However, in the absence of matched normal controls, distinguishing between germline and somatic variants becomes challenging in...
4.
Li H, Zhao P, Tian L, Lu Y, Wang X, Shao W, et al.
Front Immunol
. 2024 Dec;
15:1490590.
PMID: 39723215
Small-cell lung cancer (SCLC) is a refractory cancer with rapid growth and high aggressiveness. Extensive-stage SCLC is initially sensitive to chemotherapy; however, drug resistance and recurrence occur rapidly, resulting in...
5.
Lu Y, Li H, Zhao P, Wang X, Shao W, Liu Y, et al.
Mol Med
. 2024 Dec;
30(1):274.
PMID: 39722014
Background: Small cell lung cancer (SCLC) is a highly fatal malignancy, the complex tumor microenvironment (TME) is a critical factor affecting SCLC progression. Cancer-associated fibroblasts (CAFs) are crucial components of...
6.
Tang C, Jin Y, Zhao P, Tian L, Li H, Yang C, et al.
Zhongguo Fei Ai Za Zhi
. 2024 Nov;
27(9):645-653.
PMID: 39492579
Background: Small cell lung cancer (SCLC) is known as recalcitrant cancer with high malignancy and heterogeneity. Immunotherapy has changed the treatment pattern of extensive-disease SCLC (ED-SCLC), but the beneficiary population...
7.
Ma J, Liu D, Zhao P, Dou M, Yang X, Liu S, et al.
Front Plant Sci
. 2024 Oct;
15:1470229.
PMID: 39445144
Introduction: Changes in the rhizosphere microbiome and metabolites resulting from crop intercropping can significantly enhance crop growth. While there has been an increasing number of studies on various crop combinations,...
8.
Zhao P, Higashijima Y, Sonoda H, Morinaga R, Uema K, Oguchi A, et al.
J Pharmacol Sci
. 2024 Aug;
156(2):115-124.
PMID: 39179330
Although several studies have shown that glucocorticoids exert diuretic effects in animals and humans, the underlying mechanism responsible for the acute diuretic effect remains obscure. Here we examined the mechanism...
9.
Cui H, Li H, Liu J, Zhao P, Liu Y, Zhong R, et al.
Medicine (Baltimore)
. 2024 Jun;
103(25):e38574.
PMID: 38905387
Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer. In recent years, immunotherapy has greatly changed the treatment pattern of advanced LUAD. However, only a small proportion...
10.
Cui Y, Chen Y, Zhao P, Li S, Cheng Y, Ren X
Clin Transl Oncol
. 2024 Apr;
26(10):2522-2530.
PMID: 38662170
Purpose: Although immunotherapy improves outcomes in extensive-stage small-cell lung cancer (ES-SCLC), the search for biomarkers predicting treatment success is crucial. Natural killer (NK) cells are potential indicators in various cancers,...